Apellis stock price - View live Apellis Pharmaceuticals, Inc. chart to track its stock's price action. Find market predictions, APLS financials and market news.

 
Stock - Share Price, Short Interest, Short Squeeze, Borrow Rates (NasdaqGS). Apellis Pharmaceuticals, Inc. NasdaqGS. REAL TIME PRICE. EXTENDED HOURS. Days Range .... Are bobcats dangerous

Apellis Pharmaceuticals Inc stock price live 66.89, this page displays NASDAQ APLS stock exchange data. View the APLS premarket stock price ahead of the market session or assess the after hours quote.Stock analysis for Apellis Pharmaceuticals Inc (APLS:NASDAQ GS) including stock price, stock chart, company news, key statistics, fundamentals and company profile. 67.59 +0.70 1.05% Healthcare • Biotechnology • USA • NASD Stock Detail • Compare Perf. • Revenue • Options Chain • Save to Portfolio • Create Alert Draw Ideas …Get the latest Apellis Pharmaceuticals Inc (1JK) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and …Apellis Pharmaceuticals, Inc. Stock price BOERSE MUENCHEN Equities 1JK US03753U1060 Pharmaceuticals Market Closed - BOERSE MUENCHEN. Other stock markets. 03:44:08 2024-01-30 pm EST After market ...Apellis Pharmaceuticals (APLS) stock price, charts, trades & the US's most popular discussion forums. Free forex prices, toplists, indices and lots more.Apellis Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutic …Oct 6, 2023 ... an upgrade to "Buy" from Jefferies analysts. Apellis Pharmaceuticals (APLS) stock ... price target. Lastly, Oppenheimer downgrades AutoZone (AZO) ...Apellis Pharmaceuticals Inc Stock Price History. Apellis Pharmaceuticals Inc’s price is currently up 7.69% so far this month. During the month of February, Apellis Pharmaceuticals Inc’s stock price has reached a high of $68.17 and a low of $60.52. Over the last year, Apellis Pharmaceuticals Inc has hit prices as high as $94.75 and as low as ...Compact, single-use, on-body injector designed to enhance the patient experience of administering EMPAVELI ® (pegcetacoplan); WALTHAM, Mass., Oct. 02, 2023 (GLOBE NEWSWIRE) -- Apellis Pharmaceuticals, Inc. (Nasdaq: APLS) today announced that the U.S. Food and Drug Administration (FDA) has approved the …Stock control is important because it prevents retailers from running out of products, according to the Houston Chronicle. Stock control also helps retailers keep track of goods th...View live Apellis Pharmaceuticals, Inc. chart to track its stock's price action. Find market predictions, APLS financials and market news.Are you tired of spending endless hours searching for high-quality stock photos only to discover that they come with a hefty price tag? Look no further. In this article, we will ex...What are the best stocks to buy? Learn how you can make that decision for yourself at InvestorPlace. With the help of experienced financial advisors, InvestorPlace can give you the...On this news, the price of Apellis common stock declined nearly 24%. Thereafter, on July 20, 2023, Wedbush downgraded Apellis’ price target by more than 50%, from $86.00 per share to $40.00 per ...Analysts' Consensus ; Mean consensus. BUY ; Number of Analysts. 17 ; Last Close Price. 67.59 USD ; Average target price. 79.81 USD ; Spread / Average Target. +18.08%.The Apellis Pharmaceuticals, Inc. (NASDAQ:APLS) share price has fared very poorly over the last month, falling by a substantial 55%. Instead of being rewarded, shareholders who have already held ...Zacks Equity Research. Investors are always looking for stocks that are poised to beat at earnings season and Apellis Pharmaceuticals, Inc. APLS may be one such …Feb 16, 2024 · Price Target. Based on short-term price targets offered by 16 analysts, the average price target for Apellis Pharmaceuticals, Inc. comes to $77.19. The forecasts range from a low of $49.00 to a ... Apellis Pharmaceuticals-stock; News for Apellis Pharmaceuticals Apellis Pharmaceuticals; ... Apellis price target raised to $63 from $60 at Needham; SHARE THIS POST. FACEBOOK. TWITTER.Apellis Pharmaceuticals, Inc. price-consensus-chart | Apellis Pharmaceuticals, Inc. Quote. Zacks Rank and Other Stocks to Consider. Apellis currently carries a Zacks Rank #2 (Buy).APLS | Complete Apellis Pharmaceuticals Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview. Apellis Pharmaceuticals Inc stock price (APLS) NASDAQ: APLS. ... Apellis Pharmaceuticals Inc stock performance at a glance. Check Apellis Pharmaceuticals Inc’s past financial performance, like revenue or net income, plus the top level summary of its past and current market value.Apellis Pharmaceuticals, Inc. Stock price Deutsche Boerse AG Equities 1JK US03753U1060 Pharmaceuticals Market Closed - Deutsche Boerse AG. Other stock markets. 07:31:56 2024-02-13 am EST 5-day change ...Apellis Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutic …Apellis Pharmaceuticals, Inc. (APLS) Stock Price | Stock Quote Nasdaq - MarketScreener APELLIS PHARMACEUTICALS, INC. PDF Report Apellis Pharmaceuticals, Inc. Stock …On this news, the price of Apellis common stock declined nearly 24%. Thereafter, on July 20, 2023, Wedbush downgraded Apellis’ price target by more than 50%, from $86.00 per share to $40.00 per ...See Apellis Pharmaceuticals, Inc. (APLS) stock analyst estimates, including earnings and revenue, EPS, upgrades and downgrades.How the News Affects Stock Prices. Stock prices tick up and down constantly due to fluctuations in supply and demand. If more people want to buy a stock, its market price will increase. If more ...Apellis Pharmaceuticals, Inc. (APLS Quick Quote APLS - Free Report) shares ended the last trading session 14.7% higher at $68.35.The jump came on an impressive volume with a higher-than-average ...Dec 5, 2023 · According to 14 analyst offering 12-month price targets in the last 3 months, Apellis Pharmaceuticals has an average price target of $71.36 with a high of $93.00 and a low of $42.00. Below is a ... In depth view into APLS (Apellis Pharmaceuticals) stock including the latest price, news, dividend history, earnings information and financials. With stocks at historic highs, many individuals are wondering if the time is right to make their first foray in the stock market. The truth is, there is a high number of great stoc...Apellis Pharmaceuticals Stock Forecast. All Analysts Top Analysts Stock Price Forecast. The 18 analysts with 12-month price forecasts for APLS stock have an average target of 77.17, with a low estimate of 42 and a high estimate of 141. The average target predicts an increase of 12.20% from the current stock price of 68.78.The average stock forecast for Apellis Pharmaceuticals Inc (APLS) is 76.88 USD. This price target corresponds to an upside of 11.78%. The range of stock forecasts for Apellis is 49.49 - 111.30 USD. Based on the ratings of 23, the consensus recommendation for Apellis is BUYApellis Pharmaceuticals, Inc. (APLS) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.Apellis Pharmaceuticals Inc stock price (APLS) NASDAQ: APLS. Buying or selling a stock that’s not traded in your local currency? Don’t let the currency conversion trip you up. Convert Apellis Pharmaceuticals Inc stocks or shares into any currency with our handy tool, and you’ll always know what you’re getting. View the latest Apellis Pharmaceuticals Inc. (APLS) stock price, news, historical charts, analyst ratings and financial information from WSJ. Find the historical stock prices of Apellis Pharmaceuticals Inc. (APLS)On this news, the price of Apellis common stock declined nearly 24%. Thereafter, on July 20, 2023, Wedbush downgraded Apellis’ price target by more than 50%, from $86.00 per share to $40.00 per ...Apellis Pharmaceuticals, Inc. (APLS) Stock Price, News, Quote & History - Yahoo Finance Industry News Canada markets close in 3 hours 54 minutes S&P/TSX 20,626.06 …On average, Wall Street analysts predict. that Apellis Pharmaceuticals's share price could reach $72.47 by Jan 30, 2025. The average Apellis Pharmaceuticals stock price prediction forecasts a potential upside of 15.84% from …Related news Stock Upgrades: Apellis Pharmaceuticals Shows Rising Relative Strength. 1/29/2024 Apellis Pharmaceuticals shows rising price performance, earning an upgrade to its IBD Relative ...Apellis Pharmaceuticals Inc stock price live 66.89, this page displays NASDAQ APLS stock exchange data. View the APLS premarket stock price ahead of the market session or assess the after hours quote.You can buy and sell Apellis Pharmaceuticals (APLS) and other stocks, ETFs, and options commission-free on Robinhood with real-time quotes, market data, and relevant news. Other Robinhood Financial fees may apply, check rbnhd.co/fees for details.Oct 6, 2023 ... an upgrade to "Buy" from Jefferies analysts. Apellis Pharmaceuticals (APLS) stock ... price target. Lastly, Oppenheimer downgrades AutoZone (AZO) ...Apellis Pharmaceuticals, Inc. (APLS) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.Sep 27, 2023 ... The company's shares fell following a short-seller report on the pharmaceutical company. The stock is down more than 24% so far this year.APLS | Complete Apellis Pharmaceuticals Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.You may have a lot of questions if you are interested in investing in the stock market for the first time. One question that beginning investors often ask is whether they need a br...View the latest Apellis Pharmaceuticals Inc. (APLS) stock price, news, historical charts, analyst ratings and financial information from WSJ. What are the best stocks to buy? Learn how you can make that decision for yourself at InvestorPlace. With the help of experienced financial advisors, InvestorPlace can give you the...Buy Apellis Pharmaceuticals Inc Shares from India at $68.8 (0 Commission) today. Start investing in Apellis Pharmaceuticals Inc stocks from India now with fractional investing only on INDmoneyappApellis Pharmaceuticals ( NASDAQ: APLS) lost ~2% in the pre-market Friday after announcing that updated labeling information for its FDA-approved eye disease therapy Syfovre reflects risks related ...Apellis's Stock Under Pressure On Syfovre Safety Concerns: Analyst Slashes Price Target. Benzinga. ... Wedbush analyst has lowered the price target from $86 to $40, with a Neutral rating.Apellis Pharmaceuticals Inc. historical stock charts and prices, analyst ratings, financials, and today’s real-time APLS stock price.What is the Apellis Pharmaceuticals stock forecast? The Apellis Pharmaceuticals stock forecast for tomorrow is $ 67.50, which would represent a 0.11% gain ...Apellis Pharmaceuticals, Inc. Stock price Deutsche Boerse AG Equities 1JK US03753U1060 Pharmaceuticals Market Closed - Deutsche Boerse AG. Other stock markets. 07:31:56 2024-02-13 am EST 5-day change ...With stocks at historic highs, many individuals are wondering if the time is right to make their first foray in the stock market. The truth is, there is a high number of great stoc...On average, Wall Street analysts predict. that Apellis Pharmaceuticals's share price could reach $72.47 by Jan 30, 2025. The average Apellis Pharmaceuticals stock price prediction forecasts a potential upside of 15.84% from the current APLS share price of $62.56. Apellis has been a takeout target before, and may be again, at an acquisition price nearly twice its current market value. advertisement Apellis shares rose 32% last week, with most of the gains ...Apellis Pharmaceuticals, Inc. (APLS) Stock Price, News, Quote & History - Yahoo Finance Industry News Canada markets close in 3 hours 54 minutes S&P/TSX 20,626.06 …The latest closing stock price for Apellis Pharmaceuticals as of February 05, 2024 is 68.16. The all-time high Apellis Pharmaceuticals stock closing price was 93.31 on June 13, 2023. The Apellis Pharmaceuticals 52-week high stock price is 94.75, which is 39% above the current share price. The Apellis Pharmaceuticals 52-week low stock price is ... Apellis Pharmaceuticals Inc. (APLS) is a biotechnology company that develops and commercializes therapies for rare diseases. The stock price, …Stock Upgrades: Apellis Pharmaceuticals Shows Rising Relative Strength; Stocks With Rising Relative Price Strength: Apellis Pharmaceuticals; Meta Stock, Nvidia, Toyota, Alphabet And 12 Others ...Oct 6, 2023 ... an upgrade to "Buy" from Jefferies analysts. Apellis Pharmaceuticals (APLS) stock ... price target. Lastly, Oppenheimer downgrades AutoZone (AZO) ...Jan 26, 2024 · Feb 20, 2024 Apellis Pharmaceuticals to Host Conference Call on February 27, 2024, to Discuss Fourth Quarter and Full Year 2023 Financial Results; Feb 06, 2024 Apellis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) Oct 6, 2023 ... J. P. Morgan analyst boosted the company from neutral to overweight and raised their price target to $81 a share. This comes as the company ...Stock - Share Price, Short Interest, Short Squeeze, Borrow Rates (NasdaqGS). Apellis Pharmaceuticals, Inc. NasdaqGS. REAL TIME PRICE. EXTENDED HOURS. Days Range ...Since its IPO on the Shenzhen stock exchange, its share price has gone up every day by the exact same amount. Baofeng Technologies is China’s best performing stock this year. Since...APLS Nasdaq Stock Market • delayed by 15 minutes • CURRENCY IN USD • Pharmaceuticals. APELLIS PHARMACEUTICALS, INC. (APLS) Compare. APELLIS PHARMACEUTICALS, ...Based on short-term price targets offered by 16 analysts, the average price target for Apellis Pharmaceuticals, Inc. comes to $77.88. The forecasts range from a low of $54.00 to a high of $110.00.Real-time Price Updates for Apellis Pharmaceuticals Inc (APLS-Q), along with buy or sell indicators, analysis, charts, historical performance, news and moreApellis has been a takeout target before, and may be again, at an acquisition price nearly twice its current market value. advertisement Apellis shares rose 32% last week, with most of the gains ...The cap price of the capped call transactions is initially $63.14 per share of Apellis common stock, representing a premium of 100% above the last reported sale price of $31.57 per share of Apellis common stock on The Nasdaq Global Select Market on September 11, 2019, and is subject to certain adjustments under the terms of the capped …APLS: Apellis Pharmaceuticals Inc Stock Price Quote - NASDAQ GS - Bloomberg Subscribe S&P 500 4,975.51 –0.60% Nasdaq 15,630.78 –0.92% Crude Oil 78.27 –1.16% …Sep 27, 2023 ... The company's shares fell following a short-seller report on the pharmaceutical company. The stock is down more than 24% so far this year.Fiscal Q3 2023 ended 9/30/23. Reported on 11/1/23. Get the latest Apellis Pharmaceuticals Inc (APLS) real-time quote, historical performance, charts, and other financial …The high in the last 52 weeks of Apellis Pharmaceuticals stock was 94.75. According to the current price, Apellis Pharmaceuticals is 72.61% away from the 52 …Apellis (APLS) stock falls on the CHMP's negative recommendation to the EMA regarding the approval of intravitreal pegcetacoplan in the EU for the treatment of geographic atrophy secondary to age ...At Yahoo Finance, you get free stock quotes, up-to-date news, portfolio management resources, international market data, social interaction and mortgage rates that help you manage your financial life. Nowadays finding high-quality stock photos for personal or commercial use is very simple. You just need to search the photo using a few descriptive words and let Google do the rest...Apellis Pharmaceuticals, Inc. price-consensus-chart | Apellis Pharmaceuticals, Inc. Quote. Zacks Rank and Other Stocks to Consider. Apellis currently carries a Zacks Rank #2 (Buy).See the latest Apellis Pharmaceuticals Inc stock price (APLS:XNAS), related news, valuation, dividends and more to help you make your investing decisions.As of Q1 2023, Apellis Pharmaceuticals, Inc. (NASDAQ:APLS) was the most commonly held stock out of the 12 stocks with biggest upside potential according to analysts.Apellis Pharmaceuticals, Inc. Stock price Börse Stuttgart Equities 1JK US03753U1060 Pharmaceuticals Market Closed - Börse Stuttgart. Other stock markets. 06:12:15 2023-12-20 am EST 5-day change 1st Jan Change ...That disclosure suggested the safety issues may be unrelated to Syfovre itself, helping Apellis’ stock rebound. But at $43 apiece, shares are worth less than they were prior to Syfovre’s approval, and the company is still losing money. Apellis had a net loss of $122 million on drug sales of $95 million in the second quarter.

Apellis Pharmaceuticals Inc stocks price quote with latest real-time prices, charts, financials, latest news, technical analysis and opinions.. Coomerparty downloader

apellis stock price

Jan 19, 2024 · The stock's price-to-GF-Value ratio stands at 0.45, with a GuruFocus Value of $144.67, indicating that Apellis Pharmaceuticals Inc is currently categorized as a Possible Value Trap, Think Twice ... Apellis (APLS) stock falls on the CHMP's negative recommendation to the EMA regarding the approval of intravitreal pegcetacoplan in the EU for the treatment of geographic atrophy secondary to age ...Sep 27, 2023 ... The company's shares fell following a short-seller report on the pharmaceutical company. The stock is down more than 24% so far this year.Apellis Pharmaceuticals Inc stocks price quote with latest real-time prices, charts, financials, latest news, technical analysis and opinions. Apellis Pharma (APLS) stock experienced a sharp pre-market decline following news that it anticipates a negative opinion from a European regulator on Pegcetacoplan at its upcoming meeting. The stock fell 14.1% in early trade. After receiving a negative trend vote during an oral explanation meeting on December 13, Apellis expects …Stock control is important because it prevents retailers from running out of products, according to the Houston Chronicle. Stock control also helps retailers keep track of goods th...A high-level overview of Apellis Pharmaceuticals, Inc. (APLS) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools. If you need cash, aren’t happy with your investment returns or want to diversify your investments, you may have to liquidate some of your stocks. Buying and selling stocks is extre...Mar 11, 2019 ... ... shares at the public offering price, less underwriting discounts and commissions. All of the shares in the offering were sold by Apellis.APLS Nasdaq Stock Market • delayed by 15 minutes • CURRENCY IN USD • Pharmaceuticals. APELLIS PHARMACEUTICALS, INC. (APLS) Compare. APELLIS PHARMACEUTICALS, ...APLS Nasdaq Stock Market • delayed by 15 minutes • CURRENCY IN USD • Pharmaceuticals. APELLIS PHARMACEUTICALS, INC. (APLS) Compare. APELLIS PHARMACEUTICALS, ... Related news Stock Upgrades: Apellis Pharmaceuticals Shows Rising Relative Strength. 1/29/2024 Apellis Pharmaceuticals shows rising price performance, earning an upgrade to its IBD Relative ...APLS Nasdaq Stock Market • delayed by 15 minutes • CURRENCY IN USD • Pharmaceuticals. APELLIS PHARMACEUTICALS, INC. (APLS) Compare. APELLIS PHARMACEUTICALS, ... Since its approval, rare but serious side effects have marred an otherwise steady launch in the U.S., depressing Apellis’ stock price and, in October, triggering a major restructuring. Though Apellis has blamed faulty needles, not the treatment, for the safety problems, two weeks ago the FDA added a warning to Syfovre’s prescribing …Apellis Pharmaceuticals-stock; News for Apellis Pharmaceuticals Apellis Pharmaceuticals; ... Apellis price target raised to $63 from $60 at Needham; SHARE THIS POST. FACEBOOK. TWITTER.Apellis Pharmaceuticals Inc. (APLS) is a biotechnology company that develops and commercializes therapies for rare diseases. The stock price, …APLS's current price target is $75.93. Learn why top analysts are making this stock forecast for Apellis Pharmaceuticals at MarketBeat.Apellis Pharmaceuticals shows improving price ... IBD's proprietary RS Rating measures market leadership by showing how a stock's price action over the last 52 weeks measures up against that ....

Popular Topics